an RGD motif located near the C-terminus; however, KGD, RTS, KTS,
61
MGD, WGD, and ECD domains have also been identified [6, 7] . This
62
"RGD" binding domain is found at the tip of a flexible hairpin loop of 63 the disintegrin and is essential to the integrin-inhibitory activity [8, 9] .
64
Disintegrins inhibit platelet aggregation, and some can also inhibit 65 cancer cell growth, and/or angiogenesis [10] [11] [12] [13] [14] . expressed with activity, and some have been used to study anti-
75
thrombotic and anti-tumor activity [15] [16] [17] [18] [19] [20] [21] .
76
A group of Crotalus scutulatus scutulatus (Mohave rattlesnake) 77 identified in central Arizona contained venom that was proteolytic, 78 hemorrhagic, and had disintegrin activity [12] . From that group, RGD 79 containing disintegrins, mojastin 1 and 2 were isolated [12] . Mojastin 80 1 and 2 were medium-sized disintegrins that inhibited APD-induced 81 platelet aggregation in whole blood. The goals of this study were to carried-out as previously described [22] .
114
cDNA cloning of r-Mojastin 1
115
The cDNA was ligated into the pGEX-4 T-1 expression vector (GE Corporation, USA), and sequenced with disintegrin-specific primers.
120
The sequencing data were analyzed with ClustalW DNA alignment 121 program [23] in Biology Workbench [24] . Thrombin was removed from r-mojastin 1 using a 1 mL HiTrap™ lyophilized using a Labconco freeze dryer.
166

SDS Polyacrylamide Gel Electrophoresis
167
The disintegrins were subjected to electrophoresis by using a pre-168 cast 10-20% Tricine gel [26] tion, by impedance and turbidimetry as described previously [9, 28] . absence of recombinant disintegrin was given as 100% aggregation.
216
The IC 50 values were calculated from a dose-dependent curve using
217
Microsoft excel.
218
The inhibition of ADP-induced platelet aggregation by r-mojastin 1
219
in whole blood and PRP having the same platelet count was also 220 performed. Whole blood and PRP were adjusted to a platelet count of 221 230,000 platelets/μL, which corresponds to a hematocrit value of 30%. values. P values were calculated using a t-test, two-tailed P value on and the r-mojatin 1-GST was at ∼34 kDa ( Fig. 2A ; lane 4). (Fig. 3) .
274
The native mojastin had 47.2% coverage with the native disintegrins
(P0C7X7), and tergeminin (P22828). is shown on the lower line. The RGD-motif is shaded in gray. The underlined amino acids correspond to the amino acids in the native mojastin identified by LC-MS/MS (Fig. 3) . 
306
To insure that the most efficient IC 50 using whole blood was not a 307 factor of a lower platelet count, inhibition of platelet aggregation by r-308 mojastin 1 was repeated using an equal platelet count for both whole C. s. scutulatus [12] .
357
The physiological activities of platelets undergo three sequential steps 358 that can be studied independently of each other. These are: 1) adhesion, The mass spectrometer was operated in the data-dependent mode, in which a full scan MS was followed by MS/MS scans of the 3 most abundant ions with + 2 to + 3 charge states. (Table 3 ). In 420 our study, r-mojastin 1, using both PRP and whole blood, was more close to 1 μM), but had no effect on ADP-induced aggregation [40] . 
430
These results indicate that recombinant mojastatin 1 is a strong 431 aggregation inhibitor and can be used as a useful tool for studies of 432 integrin/ligand interaction.
433
When comparing the mojastin disintegrins, the native mojastin 434 was always more effective than its recombinant counterpart in both 435 PRP and whole blood ( Table 1 ). The IC 50 s, for inhibiting ADP-induced 436 platelet aggregation in whole blood, of the native mojastins were 3.3 437 and 2.6 times more efficient than the r-mojastin 1. Similar results
438
were observed using PRP ( Table 1) . The difference between activities 439 could be that r-mojastin 1 may not be completely folding properly in 440 the E. coli cells because disintegrins are rich in disulfide bonds [42] .
441
When comparing the inhibition of platelet aggregation IC 50 s for 442 whole blood and PRP, whole blood resulted more efficient in all 3 Fig. 4 . Comparison of inhibition of platelet aggregation using whole blood and PRP with an equal platelet count. A Chrono-Log aggregometer was used to measure ADP-induced platelet aggregation by impedance. A total of 10 μL of r-mojastin 1 at varying concentrations was added to whole blood and PRP both containing a platelet count of 230,000 platelets/μL and incubated for 4 min at 37°C prior to adding 10 μM of ADP. The IC 50 was 40 nM for whole blood and 90 nM for PRP. The vertical bars represent the standard deviation. n = 3. interpreted to be lower for whole blood (Table 3) . In order to 
456
These results were similar, although slightly more efficient, to the IC 50
457
obtained by the standard methods (Table 1) .
458
The differences between whole blood and platelet rich plasma are Hotle, Juan Salinas and Lucy Arispe of the NTRC. We thank Nora Diaz 6 platelets and incubated for 1 h at 37°C prior to adding to fibronectin-coated wells.
P-nitrophenyl phosphate (PNPP) is used as the substrate solution. The ability of platelet phosphatases to catalyze the hydrolysis of PNPP to p-nitrophenol (chromogenic product) was measured at 405 nm. The IC 50 s were 62.2 and 58.6 nM for r-mojastin 1 and native mojastin, respectively. The vertical bars represent the standard deviation. n= 3.
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